
Chris Eubank Jr vs Conor Benn seems to be off after the British Boxing Board of Management declared the bout is ‘prohibited’ after the latter examined constructive for a banned substance.
It was revealed on Wednesday that Benn, 26, has returned an ‘opposed analytical discovering for hint quantities of a fertility drug’ regarded as comifene, a substance prohibited by the World Anti-Doping Company.
An announcement from Benn’s promoter Matchroom acknowledged their fighter is ‘free to battle’ with the Londoner having subsequently handed a doping management take a look at carried out by the UK Anti-Doping Company.
Whereas each fighters have been prepared to proceed as deliberate, British boxing’s authorities insist the competition is ‘not within the pursuits of boxing’
An announcement learn: ‘On the night of 4 Oct 2022, the Board of the British Boxing Board of Management Restricted resolved that the competition between Chris Eubank Jnr. and Conor Benn scheduled to happen on 8 Oct is prohibited as it isn't within the pursuits of Boxing.’
A public exercise that includes fighters competing on the undercard on Saturday evening was underway because the information broke – with Benn and Eubank Jr nonetheless scheduled to take to the ring this afternoon.
Talking on the occasion, Benn’s promoter Eddie Hearn defined the matter was ‘with the attorneys’ with discussions on going with the Board.

Talking earlier on Wednesday, Eubank Jnr’s promoter Kalle Sauerland revealed to talkSPORT they discovered of the opposed discovering at ‘the tip of August, starting of September’.
After talking to consultants, Group Eubank concluded the ‘non-PED’ substance was not ‘giving a bonus with the fighter.’
‘On the finish of August, starting of September, there was a take a look at taken by Benn wherein there was this feminine fertility drug and that was then relayed to us when these checks got here again,’ Sauerland mentioned.
‘The British board follows UKAD and all these checks have been introduced to us as adverse and that’s the place from a licensing viewpoint that now we have obtained.
‘It’s a non-PED, however on the similar time it could elevate the testosterone ranges, however the consultants we consulted couldn’t see that it was giving a bonus.
‘So, on the idea of that, we mentioned with a very powerful individual on our aspect and that’s the athlete and he was pleased to proceed.
‘We spoke to Benn straight, there was a direct dialogue between the 2, however I’m not privileged to that dialogue, I wasn’t a part of that dialogue…
‘We've to deal with the present on Saturday and we will’t be distracted by something.’
.
.
Post a Comment